{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:15:12Z","timestamp":1791321312186,"version":"4.3.1"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["106-2321-B-006 -008"],"award-info":[{"award-number":["106-2321-B-006 -008"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["103-2320-B-006-028-MY2"],"award-info":[{"award-number":["103-2320-B-006-028-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2017.02635","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T23:20:49Z","timestamp":1516144849000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":106,"title":["Lauric Acid Is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model"],"prefix":"10.3389","volume":"8","author":[{"given":"Hsiao-Ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenn-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagat","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Zhen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jane","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Pin","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Paredes-Sabja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hsiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"980","DOI":"10.4315\/0362-028x-55.12.980","article-title":"Inhibition of bacterial spore growth by fatty acids and their sodium salts.","volume":"55","author":"Ababouch","year":"1992","journal-title":"J. Food Prot."},{"key":"B2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrmicro.2016.108","article-title":"Clostridium difficile colitis: pathogenesis and host defence.","volume":"14","author":"Abt","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrgastro.2010.190","article-title":"Clostridium difficile infection: epidemiology, risk factors and management.","volume":"8","author":"Ananthakrishnan","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/srep31749","article-title":"New insights into the mode of action of the lantibiotic salivaricin B.","volume":"6","author":"Barbour","year":"2016","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s007050170146","article-title":"Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid.","volume":"146","author":"Bartolotta","year":"2001","journal-title":"Arch. Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1128\/AAC.45.11.3209-3212.2001","article-title":"In vitro killing of Candida albicans by fatty acids and monoglycerides.","volume":"45","author":"Bergsson","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1128\/JB.00908-15","article-title":"Reexamining the germination phenotypes of several Clostridium difficile strains suggests another role for the CspC germinant receptor.","volume":"198","author":"Bhattacharjee","year":"2015","journal-title":"J. Bacteriol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1099\/jmm.0.028514-0","article-title":"Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291.","author":"Buckley","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5009\/gnl.2014.8.1.1","article-title":"Clostridium difficile infection: a worldwide disease","volume":"8","author":"Burke","year":"2014","journal-title":"Gut Liver"},{"key":"B10","first-page":"991","article-title":"Novel antibacterial activity of monolaurin compared with conventional antibiotics against organisms from skin infections: an in vitro study.","volume":"6","author":"Carpo","year":"2007","journal-title":"J. Drugs Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1053\/j.gastro.2008.09.002","article-title":"A mouse model of Clostridium difficile-associated disease.","volume":"135","author":"Chen","year":"2008","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1189\/jlb.71.3.388","article-title":"The role of PPARs in inflammation and immunity.","volume":"71","author":"Clark","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/549691","article-title":"PPARgamma and the innate immune system mediate the resolution of inflammation.","volume":"2015","author":"Croasdell","year":"2015","journal-title":"PPAR Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1093\/jac\/dku116","article-title":"Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model.","volume":"69","author":"Crowther","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1128\/JB.01980-12","article-title":"Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile.","volume":"195","author":"Dapa","year":"2013","journal-title":"J. Bacteriol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4161\/gmic.25862","article-title":"Biofilm formation by Clostridium difficile.","volume":"4","author":"Dapa","year":"2013","journal-title":"Gut Microbes"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11746-014-2562-7","article-title":"The properties of lauric acid and their significance in coconut oil.","volume":"92","author":"Dayrit","year":"2015","journal-title":"J. Am. Oil Chem. Soc."},{"key":"B18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/jn\/131.2.242","article-title":"Consumption of a solid fat rich in lauric acid results in a more favorable serum lipid profile in healthy men and women than consumption of a solid fat rich in trans-fatty acids.","volume":"131","author":"de Roos","year":"2001","journal-title":"J. Nutr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1128\/IAI.00147-12","article-title":"The Clostridium difficile spo0A gene is a persistence and transmission factor.","volume":"80","author":"Deakin","year":"2012","journal-title":"Infect. Immun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.fm.2014.07.022","article-title":"Survival of Clostridium difficile spores at low temperatures.","volume":"46","author":"Deng","year":"2015","journal-title":"Food Microbiol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1610-3","article-title":"Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.","volume":"16","author":"Desai","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01698","article-title":"Chemical and stress resistances of Clostridium difficile spores and vegetative cells.","volume":"7","author":"Edwards","year":"2016","journal-title":"Front. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/481068","article-title":"Impact of a traditional dietary supplement with coconut milk and soya milk on the lipid profile in normal free living subjects.","volume":"2013","author":"Ekanayaka","year":"2013","journal-title":"J. Nutr. Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/nutrit\/nuw002","article-title":"Coconut oil consumption and cardiovascular risk factors in humans.","volume":"74","author":"Eyres","year":"2016","journal-title":"Nutr. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.chom.2014.11.003","article-title":"Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance.","volume":"16","author":"Ferreyra","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1128\/AAC.05151-11","article-title":"Antibacterial activity of sphingoid bases and fatty acids against Gram-positive and Gram-negative bacteria.","volume":"56","author":"Fischer","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1128\/JB.02575-14","article-title":"Spore cortex hydrolysis precedes dipicolinic acid release during Clostridium difficile spore germination.","volume":"197","author":"Francis","year":"2015","journal-title":"J. Bacteriol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1365-2672.1971.tb01019.x","article-title":"Antibacterial activity of long chain fatty acids and the reversal with calcium, magnesium, ergocalciferol and cholesterol.","volume":"34","author":"Galbraith","year":"1971","journal-title":"J. Appl. Bacteriol."},{"key":"B29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ajcn\/80.3.550","article-title":"Saturated fats: What dietary intake?","volume":"80","author":"German","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1042\/EBC20160062","article-title":"Insights into drug resistance mechanisms in Clostridium difficile.","volume":"61","author":"Harnvoravongchai","year":"2017","journal-title":"Essays Biochem."},{"key":"B31","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4315\/0362-028X-69.7.1611","article-title":"Antimicrobial activity of potassium hydroxide and lauric acid against microorganisms associated with poultry processing.","volume":"69","author":"Hinton","year":"2006","journal-title":"J. Food Prot."},{"key":"B32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.archoralbio.2011.01.011","article-title":"Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms.","volume":"56","author":"Huang","year":"2011","journal-title":"Arch. Oral Biol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166159","article-title":"Predominance of Clostridium difficile ribotypes 017 and 078 among toxigenic clinical isolates in Southern Taiwan.","volume":"11","author":"Hung","year":"2016","journal-title":"PLOS ONE"},{"key":"B34","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/infdis\/jiv184","article-title":"Proton-pump inhibitor exposure aggravates Clostridium difficile\u2013associated colitis: evidence from a mouse model.","volume":"212","author":"Hung","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1365-2109.2011.02857.x","article-title":"Antibacterial effect of short-chain fatty acids on gnotobiotic Artemia franciscana nauplii against Vibrio parahaemolyticus.","volume":"43","author":"Immanuel","year":"2012","journal-title":"Aquacult. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jinf.2009.03.010","article-title":"Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.","volume":"58","author":"Johnson","year":"2009","journal-title":"J. Infect."},{"key":"B37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1128\/AAC.2.1.23","article-title":"Fatty acids and derivatives as antimicrobial agents.","volume":"2","author":"Kabara","year":"1972","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","doi-asserted-by":"crossref","first-page":"1017S","DOI":"10.1093\/ajcn\/60.6.1017S","article-title":"Effects of fats and fatty acids on blood lipids in humans: an overview.","author":"Katan","year":"1994","journal-title":"Am. J. Clin. Nutr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.foodcont.2015.08.022","article-title":"Highly enhanced bactericidal effects of medium chain fatty acids (caprylic, capric, and lauric acid) combined with edible plant essential oils (carvacrol, eugenol, beta-resorcylic acid, trans-cinnamaldehyde, thymol, and vanillin) against Escherichia coli O157:H7.","volume":"60","author":"Kim","year":"2016","journal-title":"Food Control"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1111\/1462-2920.13696","article-title":"The alternative sigma factor sigmaB plays a crucial role in adaptive strategies of Clostridium difficile during gut infection.","volume":"19","author":"Kint","year":"2017","journal-title":"Environ. Microbiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijantimicag.2005.08.020","article-title":"In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA).","volume":"27","author":"Kitahara","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B42","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.94.9.4318","article-title":"Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.","volume":"94","author":"Kliewer","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01411","article-title":"Immunization with recombinant TcdB-encapsulated nanocomplex induces protection against Clostridium difficile challenge in a mouse model.","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1093\/cid\/cis338","article-title":"Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI.","author":"Louie","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000260661","article-title":"Anticariogenicity of dietary glycerol monolaurin in rats.","volume":"17","author":"Lynch","year":"1983","journal-title":"Caries Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/QCO.0000000000000320","article-title":"New and emerging therapies for Clostridium difficile infection.","volume":"29","author":"Martin","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrgastro.2016.25","article-title":"Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.","volume":"13","author":"Martin","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3109\/00365529409094863","article-title":"Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile.","volume":"29","author":"May","year":"1994","journal-title":"Scand. J. Gastroenterol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamainternmed.2015.42","article-title":"Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection.","volume":"175","author":"McDonald","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/427113","article-title":"A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes.","volume":"40","author":"McEllistrem","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1517\/14656566.2010.485614","article-title":"Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection.","volume":"11","author":"Miller","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1038\/jid.2009.93","article-title":"Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.","volume":"129","author":"Nakatsuji","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3382\/ps.2011-01498","article-title":"Antimicrobial activity of butyrate glycerides toward Salmonella Typhimurium and Clostridium perfringens.","volume":"90","author":"Namkung","year":"2011","journal-title":"Poult. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1111\/j.1365-2672.2009.04622.x","article-title":"In vitro antimicrobial activity and mechanism of action of novel carbohydrate fatty acid derivatives against Staphylococcus aureus and MRSA.","volume":"108","author":"Nobmann","year":"2010","journal-title":"J. Appl. Microbiol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-160","article-title":"Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism.","volume":"15","author":"Pettit","year":"2014","journal-title":"BMC Genomics"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00365","article-title":"Characterization of chicken IgY specific to Clostridium difficile R20291 spores and the effect of oral administration in mouse models of initiation and recurrent disease.","volume":"7","author":"Pizarro-Guajardo","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"13467","DOI":"10.1073\/pnas.1002199107","article-title":"Structural organization of the functional domains of Clostridium difficile toxins A and B.","volume":"107","author":"Pruitt","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1128\/AEM.01589-10","article-title":"Moist-heat resistance, spore aging, and superdormancy in Clostridium difficile.","volume":"77","author":"Rodriguez-Palacios","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1128\/AAC.49.8.3187-3191.2005","article-title":"In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.","volume":"49","author":"Rouse","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B60","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/AAC.27.5.841","article-title":"Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles.","volume":"27","author":"Ruhr","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"B61","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1128\/JB.182.9.2668-2671.2000","article-title":"Equivalence of lauric acid and glycerol monolaurate as inhibitors of signal transduction in Staphylococcus aureus.","volume":"182","author":"Ruzin","year":"2000","journal-title":"J. Bacteriol."},{"key":"B62","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4315\/0362-028X-63.11.1503","article-title":"Bacterial spore inhibition and inactivation in foods by pressure, chemical preservatives, and mild heat.","volume":"63","author":"Shearer","year":"2000","journal-title":"J. Food Prot."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1089\/jmf.2012.0303","article-title":"Antimicrobial effects of virgin coconut oil and its medium-chain fatty acids on Clostridium difficile.","volume":"16","author":"Shilling","year":"2013","journal-title":"J. Med. Food"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.20","article-title":"Clostridium difficile infection.","volume":"2","author":"Smits","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1128\/JB.01765-07","article-title":"Bile salts and glycine as cogerminants for Clostridium difficile spores.","volume":"190","author":"Sorg","year":"2008","journal-title":"J. Bacteriol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"M142","DOI":"10.1111\/j.1750-3841.2011.02526.x","article-title":"Antimicrobial activity of lauric arginate-coated polylactic acid films against Listeria monocytogenes and Salmonella typhimurium on cooked sliced ham.","volume":"77","author":"Theinsathid","year":"2012","journal-title":"J. Food Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/00071669708417941","article-title":"Antibacterial activity of formic and propionic acids in the diet of hens on Salmonellas in the crop.","volume":"38","author":"Thompson","year":"1997","journal-title":"Br. Poult. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e768","DOI":"10.1016\/j.ijid.2012.07.010","article-title":"Risk factors for development of Clostridium difficile infection due to BI\/NAP1\/027 strain: a meta-analysis.","volume":"16","author":"Vardakas","year":"2012","journal-title":"Int. J. Infect. Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/17474124.2017.1344551","article-title":"Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection.","volume":"11","author":"Villafuerte Galvez","year":"2017","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa1602615","article-title":"Bezlotoxumab for prevention of recurrent Clostridium difficile infection.","volume":"376","author":"Wilcox","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1099\/jmm.0.039040-0","article-title":"Destructive effects of butyrate on the cell envelope of Helicobacter pylori.","author":"Yonezawa","year":"2012","journal-title":"J. Med. Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.02635\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T11:24:30Z","timestamp":1693481070000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.02635\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":72,"alternative-id":["10.3389\/fmicb.2017.02635"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2017.02635","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"article-number":"2635"}}